Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
http://www.newtrail.ualberta.ca Medicines and Drugs 7 Antiviral Drugs (SL + HL) D7 Antivirals - Assessment Statements D.7.1 State how viruses differ from bacteria. ! D.7.2 Describe the different ways in which antiviral drugs work. ! D.7.3 Discuss the difficulties associated with solving the AIDS problem. Some Viral Diseases chicken pox cold / influenza hepatitis swine flu (H1N1) Acquired Immunodeficiency Syndrome rabies Viruses - Background There are many types of viruses, with a wide range of structures. These features are common to most viruses: viral envelope smaller than bacteria genetic material (DNA or RNA) envelope glycoproteins core proteins Viruses (on their own) are non-living. Viruses vs Bacteria viruses bacteria made of cells? ✘ ✔ reproduce on their own? ✘ ✔ carry out metabolic processes on their own? ✘ ✔ living or non-living? non-living living how do they cause disease? “hijack cells” ... release toxins Viruses - Life Cycle Viruses damage cells by invading them and taking over their metabolic processes. Virus attaches to the cell surface and enters the cell. Virus duplicates itself using its own enzymes and cell nutrients and energy. ! Cell lyses, releasing many new virus particles.! http://whyfiles.org/2012/biobombs-blast-cancer/ Antiviral drugs target one or more of these steps. Antiviral Drug Action Antiviral drugs inhibit one part of the viral life cycle. ✗ ✗ 1. Block the attachment of the virus to cell surfaces and prevent it from entering cells. difficult to find drugs that block the attachment of viruses 2. Block viruses from using their own enzymes or the host cell materials to copy viral genetic material and make new virus particles. e.g. AZT and acyclovir ✗ 3. Prevent viruses from exiting host cells (and thereby stopping the spread of the virus). e.g. Tamiflu Antiviral Drug Action Example 1: Acyclovir used in the treatment of herpes ✗ similar structure to guanosine - a building block of DNA adding acyclovir instead of guanosine stops replication of the viral genetic material blocks the replication of viral genetic material Antiviral Drug Action Example 2: AZT (azidothymidine) used in the treatment of AIDS ✗ inhibits the HIV enzyme (reverse transcriptase) needed to copy the viral genetic material ∴ no new HIV virus particles form ∴ spread of HIV slowed down targets HIV replication only because RT is not found in human cells Antiviral Drug Action Example 3: Tamiflu used in the treatment of influenza ✗ inhibits the release of newly formed virus particles inhibits the activity of a viral enzyme (neuraminidase) that acts on cell membranes ∴ spread of the infection is slowed Antiviral Drug Action Treating viral diseases is difficult. 1. Viruses are “hidden” within host cells, and are often dormant for a period of time. ∴ difficult for a drug to locate the virus 2. Viruses multiply rapidly. ∴ spread quickly before symptoms appear and before immune system can respond 3. Viruses have a tendency to mutate easily. ∴ develop resistance to antiviral drugs 4. Viruses cannot be killed with a standard approach ∴ Unlike bacteria with similar metabolic processes, viruses lack subunits that prohibit a standard approach ∴ Each requires a specially-targeted drug to change virus on a genetic level Difficulties with the AIDS Pandemic HIV activity 1. HIV targets a cell in the immune system (helper-T cell) that co-ordinates the immune response. body is not able to fight infection on its own 2. HIV mutates very rapidly within a single patient. more new HIV variants produced each year than influenza viruses 3. HIV is dormant for several years after the initial infection. anti-HIV drugs only target enzymes used during the replication of new virus particles 4. Drug options are limited. Difficulties with the AIDS Pandemic societal and cultural factors 1. anti-HIV drugs are very costly prevalence of AIDS in developing regions - 95% limited access - 8% of people needing HIV drugs receive it 2. AIDS stigma prevents people from seeking testing and/or treatment compulsory testing for employment http://hart-hiv.org/author/admin/